Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Piketty

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Presse Medicale (Paris, France : 1983)|February 25, 2000
[The 39th ICAAC (San Francisco, September 1999). HIV infection in clinical practice]C Piketty
Journal of Investigational Allergology & Clinical Immunology|July 2, 2021
Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic DermatitisN Freemantle, C Piketty
Annales De Medecine Interne|January 1, 1996
[Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection]C Piketty, J Gilqouin, M Kazatchkine
Presse Medicale (Paris, France : 1983)|October 8, 1994
[Idiopathic CD4 lymphocytopenia]C Piketty, L Weiss, M Kazatchkine
The Journal of Infectious Diseases|August 1, 1995
Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patientsC Piketty, J Gilquin, M D Kazatchkine
Vox Sanguinis|January 1, 1994
Immunomodulation of autoimmune and systemic inflammatory diseases with intravenous immunoglobulinL Mouthon, C Piketty, M D Kazatchkine
Journal of Acquired Immune Deficiency Syndromes|May 1, 1994
Successful treatment of HIV-related thrombocytopenia with didanosine (ddI)C Piketty, J Gilquin, M D Kazatchkine
Antimicrobial Agents and Chemotherapy|August 1, 1990
In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected miceC Piketty, F Derouin, B Rouveix, et al.
AIDS (London, England)|March 14, 2000
Effect of interferon and ribavirin on HIV viral loadA Landau, D Batisse, C Piketty, et al.
AIDS (London, England)|September 14, 2000
Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapyA Landau, D Batisse, C Piketty, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Presse Medicale (Paris, France : 1983)|February 25, 2000
[The 39th ICAAC (San Francisco, September 1999). HIV infection in clinical practice]C Piketty
Journal of Investigational Allergology & Clinical Immunology|July 2, 2021
Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic DermatitisN Freemantle, C Piketty
Annales De Medecine Interne|January 1, 1996
[Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection]C Piketty, J Gilqouin, M Kazatchkine
Presse Medicale (Paris, France : 1983)|October 8, 1994
[Idiopathic CD4 lymphocytopenia]C Piketty, L Weiss, M Kazatchkine
The Journal of Infectious Diseases|August 1, 1995
Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patientsC Piketty, J Gilquin, M D Kazatchkine
Vox Sanguinis|January 1, 1994
Immunomodulation of autoimmune and systemic inflammatory diseases with intravenous immunoglobulinL Mouthon, C Piketty, M D Kazatchkine
Journal of Acquired Immune Deficiency Syndromes|May 1, 1994
Successful treatment of HIV-related thrombocytopenia with didanosine (ddI)C Piketty, J Gilquin, M D Kazatchkine
Antimicrobial Agents and Chemotherapy|August 1, 1990
In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected miceC Piketty, F Derouin, B Rouveix, et al.
AIDS (London, England)|March 14, 2000
Effect of interferon and ribavirin on HIV viral loadA Landau, D Batisse, C Piketty, et al.
AIDS (London, England)|September 14, 2000
Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapyA Landau, D Batisse, C Piketty, et al.
Pageof 6